Chimin(SH:603222) Zheng Quan Zhi Xing·2025-07-11 09:16Group 1 - The company expects a net profit attributable to the parent company for the first half of 2025 to be between -55 million yuan and -46 million yuan, indicating a significant loss compared to a profit of 25.45 million yuan in the same period last year [2][3] - The expected net profit excluding non-recurring gains and losses for the first half of 2025 is also projected to be between -55 million yuan and -46 million yuan [2][3] - The decline in performance is primarily attributed to a decrease in sales revenue of safety syringes and pre-filled catheter flushing devices due to the impact of the "He Qinghong seal engraving incident" and U.S. tariff policies, leading to a 40% drop in export revenue and an 82% decline in gross profit for safety syringes [2][3] Group 2 - The company has further made a provision for inventory impairment of approximately 20 million yuan for pre-filled catheter flushing devices and safety syringes based on cautious principles and current market sales conditions [3] - The sales revenue of pre-filled catheter flushing devices and safety syringes (domestic sales) has decreased by approximately 92% compared to the same period last year, significantly reducing the profits from these products [2][3] - The performance forecast is based on preliminary estimates and has not been audited by an accounting firm, with no significant uncertainties expected to affect the accuracy of the forecast [3]